Even for the established cardiac marker NT-proBNP, important determinants exist leading to differences in circulating levels; renal failure tends to increase natriuretic peptide levels, whereas patients with obesity show lower levels of NT-proBNP [51,52]. This evidence concerns the gene NPPB and Renal insufficiency.